Moreover, with the support of molecular docking, we demonstrate that bufalin directly binds to BCAT1 and increases the sensitivity of pancreatic cancer cells to gemcitabine and 5-fluorouracil. Here, BCAT1 is linked to familial pancreatic carcinoma.